MKMitsuo Kusano

Mitsuo Kusano

*This is an algorithmically generated author record based on publicly available information.

Mitsuo Kusano has a total of 39 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Basic Aspects of ICG Fluorescence Imaging of the Liver

    by Mitsuo Kusano, Seiji Ohtsubo, Shingo Shimada

  • Fluorescent Navigation Surgery for Gastrointestinal Tract Cancers: Detection of Sentinel Nodes, Tumor Tattooing, and Harvesting of Lymph Nodes

    by Mitsuo Kusano, Hiromi Ono, Yasushi Danjo, Futoshi Kawamata, Yusuke Tajima, Seiji Ohtsubo, Shingo Shimada, Kaname Koyanagi


  • Open Access

    Macro- and microscopic findings of ICG fluorescence in liver tumors

    by Shingo Shimada, Seiji Ohtsubo, Kazuhiro Ogasawara, Mitsuo Kusano

    Reports detailing microscopic observations of indocyanine green (ICG) fluorescence imaging (IFI) in hepatocellular carcinoma (HCC) and metastatic liver cancer are rare. We were able to perform macro- and microscopic IFI results in postoperative paraffin-embedded tissue samples and formalin-fixed specimens from liver tumors. Between April 2010 and March 2014, 19 patients with HCC or liver metastases of colorectal tumors underwent liver resection. ICG solution was injected into the peripheral vein from 14 to 2 days prior to operation. We observed liver tumor IFI during the laparotomy and IFI in resected liver sections using a photo dynamic emission (PDE) camera. The IFI of paraffin-embedded tissue samples was observed using a charge-coupled device (CCD) camera. Moreover, we microscopically performed tissue section IFI using a fluorescence microscope with an ICG-B-NQF. We performed that IFI characteristics depended on tumor type macroscopically and microscopically. In normal liver tissue, fluorescence consistent with the bile canaliculus was observed. HCC had heterogeneous IFI, forming a total or partial tumor and rim pattern. In metastatic carcinoma, we performed that non-tumor cells in the marginal region showed fluorescence and tumor cells in the central region did not fluoresce. We confirmed that the variations of ICG fluorescence imaging patterns reflect different tumor characteristics in not only macroscopic imaging as previous reports but also microscopic imaging. Moreover, the ICG fluorescence method is useful for postoperative pathological detection of microscopic lesions in histopathological specimens. ICG fluorescence in paraffin-embedded tissue samples and formalin-fixed specimens is preserved in the long term.


    • 1 December 2012
      • Vol. 39  (13) , 2549-52

    [Distal gastrectomy for initially unresectable gastric cancer with pyloric stenosis following gastrojejunostomy and S-1 plus CDDP chemotherapy].

    by Masao Sunahara, Tomoaki Kawai, Yoshihide Nagasako, Seiji Kobayashi, Manabu Takahashi, Kazuhiro Ogasawara, Mitsuo Kusano, Kenji Kinoshita, Takuto Miyagishima

    We report a case of advanced gastric cancer with pyloric stenosis, in which a curative resection was performed following gastrojejunostomy and S-1 based chemotherapy. A 46-year-old female presenting with vomiting was diagnosed with unresectable gastric cancer with pyloric stenosis after a detailed examination. She underwent laparotomy, which revealed a T4 tumor invading the pancreas head and involving the gallbladder. A gastrojejunostomy was performed. After the operation, chemotherapy of S-1(100mg/body, days 1-21)plus cisplatin(85mg/body, day 8)was administered. After 4 courses, the tumor size was markedly reduced upon imaging examinations. Six months after gastrojejunostomy, distal gastrectomy was curatively performed. The pathological findings were type 3, por1, pT4a(SE), pN1, M0, pStage III A. After 5 courses of S-1(100mg/day, days 1-28)as adjuvant chemotherapy, she had a recurrence at a lymph node behind the pancreas head. Despite irinotecan+cisplatin following docetaxel therapy, she had no effective benefits and died from the cancer 17 months after the first operation. The prognosis of unresectable gastric cancer with pyloric stenosis is not promising; however, gastrojejunostomy following S-1-based chemotherapy could lead such patients to curative resection and a longer survival time.

  • Gastric and Intestinal Phenotypic Marker Expression in Early Differentiated-Type Tumors of the Stomach: Clinicopathologic Significance and Genetic Background

    by Yusuke Tajima, Kimiyasu Yamazaki, Reiko Makino, Nobukazu Nishino, Shigeo Aoki, Masanori Kato, Koji Morohara, Tsutomu Kaetsu, Mitsuo Kusano

    Purpose: Gastric and intestinal phenotypic cell markers are expressed in gastric carcinomas, irrespective of their histologic type. In the present study, we determined the clinicopathologic significance of phenotypic marker expression in early-stage gastric differentiated-type tumors and the association between marker expression and genetic alterations. Experimental Design: Phenotypic marker expression was determined by examining the expressions of human gastric mucin (HGM), MUC6, MUC2, and CD10 in 63 gastric adenomas, 133 early differentiated-type carcinomas, and 24 follow-up cases with gastric adenoma. Tumors were classified into gastric, gastric and intestinal mixed, or intestinal phenotypes according to the immunopositivity of the above markers. The presence of mutations in APC, K-ras, and p53 and the microsatellite instability status were also determined in all tumors. Results: The expressions of HGM and MUC6, representing gastric or gastric and intestinal mixed phenotypes, were significantly associated with high-grade atypia in the 63 gastric adenomas. Among the 133 early differentiated-type carcinomas, HGM expression was significantly associated with mixed-type (with an undifferentiated-type component) tumors and lymph node metastasis. MUC2 expression was inversely associated with submucosal invasion. A multivariate analysis revealed that gastric adenomas were significantly associated with the intestinal phenotype and were inversely associated with p53 mutation compared with early differentiated-type carcinomas. Among all 196 tumors, APC mutation was significantly associated with CD10 expression and the intestinal phenotype and was inversely associated with the expressions of HGM and MUC6. The microsatellite instability status was significantly associated with MUC6 expression. Malignant transformation from gastric adenoma to carcinoma was shown in 5 of the 24 follow-up cases of gastric adenoma. The malignant transformation was significantly associated with the gastric and intestinal mixed phenotype and was inversely associated with APC mutation. No malignant transformation was found in intestinal phenotype gastric adenomas with APC mutation. Conclusions: Our present findings show that phenotypic marker expression is associated with tumor aggressiveness during the early stage of gastric differentiated-type tumors. Differences in the biological behavior of tumors with different phenotypes may result from differences in the genetic backgrounds during the incipient phase of gastric tumorigenesis.


  • RATIONALE LYMPH NODE DISSECTION FOR SUBMUCOSAL GASTRIC CANCER IN TERMS OF LYMPH NODE METASTASIS AND TYPE OF RECURRENCE

    by Satoshi Suzuki, Koji Morohara, Kimiyasu Yamazaki, Tomomi Yamazaki, Yusuke Tajima, Hiroyuki Nagayama, Koichi Takamura, Tsutomu Kaetsu, Masatoshi Kawamura, Mitsuo Kusano

  • Open Access

    Histopathologic findings predicting lymph node metastasis and prognosis of patients with superficial esophageal carcinoma

    by Yusuke Tajima, Yukihiro Nakanishi, Atsushi Ochiai, Yuji Tachimori, Hoichi Kato, Hiroshi Watanabe, Hajime Yamaguchi, Kimio Yoshimura, Mitsuo Kusano, Tadakazu Shimoda